In vivo evaluation of two novel controlled-release nitrendipine formulations

Drug Development and Industrial Pharmacy

Volumn 31, Issue 7, 2005, Pages 589-595

  Yang, Mingshi ^a   Cui, Fude ^b   You, Bengang ^b   Yang, Minghua ^c   Tao, Anjin ^b   Cun, Dongmei ^b   Kawashima, Yoshiaki ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c SHANGHAI INSTITUTE FOR FOOD AND DRUG CONTROL   (China)

^d GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Controlled release formulation; Nitrendipine; Pharmacokinetics; Relative bioavailability

Indexed keywords

AEROSIL; ETHYL CELLULOSE; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE ACETATE SUCCINATE; HYDROXYPROPYLMETHYLCELLULOSE PHTHALATE; MICROSPHERE; NIMODIPINE; NITRENDIPINE;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SUSTAINED RELEASE PREPARATION; TABLET;

BIOLOGICAL AVAILABILITY; CALCIUM CHANNEL BLOCKERS; CROSS-OVER STUDIES; DELAYED-ACTION PREPARATIONS; HUMANS; MALE; MICROSPHERES; NITRENDIPINE;

EID: 25144446181     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040500215974     Document Type: Article

References (10)

1. Baksi, A., & Edwards, J. S. (1989). Pharmacokinetics of nitrendipine in the elderly. Journal of Cardiovascular Pharmacology, 14(Suppl. 10), S33-S35.
2. Cui, F. D., Yang, M. S., Jiang, Y. Y., Cun, D. M., Lin, W. H., Fan, Y. L., & Kawashima, Y. (2003). Design of sustained-release nitrendipine microspheres having solid dispersion structure by quasi-emulsion solvent diffusion method. Journal of Controlled Release, 91, 375-384.
3. Janis, R. A., Krol, G. J., Noe, A. J., & Pan, M. (1983). Radioreceptor and high-performance liquid chromatographic assays for the calcium channel antagonist nitrendipine in serum. Journal of Clinical Pharmacology, 23, 266-273.
4. Lobo, J., Jack, D. B., & Kendall, M. J. (1987). Inter- and intra-subject variability of nitrendipine and the effect of food. European Journal of Clinical Pharmacology, 32, 357-360.
5. Mikus, G., Mast, V., Fischer, C., Machleidt, C., Kuhlmann, U., & Eichelbaum, M. (1991). Pharmacokinetics, bioavailability, metabolism and acute and chronic antihypertensive effects of nitrendipine in patients with chronic renal failure and moderate to severe hypertension. British Journal of Clinical Pharmacology, 31, 313-322.
6. Ramsch, K. D., Graefe, K. H., Scherling, D., Sommer, J., & Ziegler, R. (1986). Pharmacokinetics and metabolism of calcium-blocking agents nifedipine, nitrendipine, and nimodipine. American Journal of Nephrology, 6(Suppl. 1), 73-80.
7. Skelly, J. P., Barr, W. H., Zenet, L. Z., Doluisio, J. T., Goldberg, A. H., Levy, G., Lowenthal, D. T., Robinson, J. R., Shah, V. P., Temple, R. J., & Yacobi, A. (1987). Report of the workshop on controlled-release dosage forms: issues and controversies. Pharmaceutical Research, 4, 75-77.
8. Yang, M. S., Cui, F. D., You, B. G., You, J., Wang, L., Zhang, L. Q., & Kawashima, Y. (2004a). A novel pH-dependent gradient-release delivery system for nitrendipine I. Manufacturing, evaluation in vitro and bioavailability in healthy dogs. Journal of Controlled Release, 98, 219-229.
9. Yang, M. S., Cui, F. D., You, B. G., Wang, L., Yue, P., & Kawashima, Y. (2004b). A novel pH-dependent gradient-release delivery system for nitrendipine II. Investigations of the factors affecting the release behaviors of the system. International Journal of Pharmaceutics, 286, 99-109.
10. Zhu, Z. Y., Mao, F. F., & Zhu, J. B. (1990). Studies on nitrendipine sustained-release tablets. Chinese Medical & Industrial Journal, 27, 499-502.